News Articles for Brian Leedman

BlinkLab shares soar on ASX debut

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

BlinkLab shares have surged more than 30 per cent on its debut listing on the Australian Securities Exchange.

Pfizer deal shows local potential

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Limitless: ResApp co-founder Brian Leedman talks about the challenges of commercialising tech in Perth after the company was acquired by Pfizer for $179 million.

Board Moves August 16, 2022

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Phillip Gallagher, Glen Edwards, Alexander Biggs, Adam Schofield, Dan Smith, Tom Duthy, Mark Davies, Brian Leedman, Krista Bates, Allan Cripps, Gerald Quigley, Andrew Metcalfe, Alastair Beard, Phillip MacLeod, Damon Cox, Ranko Matic, and Matthew Foy.

Board Moves May 18, 2021

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Richard Nicholls-Maltman, Eddy Wu, Mathew Longworth, Andrew Daley, Brian Leedman, Anton Uvarov, and Shaun Hardcastle.

Board Moves October 19, 2020

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Nicholas Ong, ZhaoYa Wang, Brian Leedman, David Cantor, Peter Griffiths, John Welborn, Stuart Gale, Phil Montgomery, Peter Thomas, Mark Pearce, Luca Giacovazzi, and Trevor Benson.

Major pandemic role for medtech

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

SPECIAL REPORT: As markets struggle under the pressure of the COVID-19 pandemic, the medtech industry has found itself with an unparalleled, if challenging, opportunity.

Research skills not matched by returns

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.

WA stocks absent from tech index

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The ASX has launched a technology index with 46 constituent companies and while several, such as Nearmap and ResApp Health, have a WA connection, none are based in Perth.

NeuroScientific set for ASX debut

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Nedlands-based NeuroScientific Biopharmaceuticals, which has been bankrolled by the Clough family, is set to begin trading on the ASX tomorrow, after raising $6 million via an initial public offering.

Board Moves December 29-31, 2017

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

ResApp Health, a digital health company developing smartphone applications for the diagnosis and management of respiratory disease has appointed Nathan Buzza as non-executive director.

Board Moves Feb 17-22 2016

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Ardiden has appointed Bradley Boyle as executive director and Michael Stares as general manager – Canadian operations. Mr Boyle was formerly a managing director of Triton Minerals.

App/tech business of the week – ResApp Health

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

ResApp Health develops digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.

ResApp starts trading on ASX

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based biotech company ResApp Health had a steady first day of trade on the ASX today, after being acquired by Narhex Life Sciences in an $11 million backdoor listing.

Narhex asks investors to cough up $4m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Narhex Life Sciences has launched a $4 million capital raising to support development of a phone app that can diagnose illness by analysing the sound of a cough.

ASX opens back door

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The number of backdoor listings or reverse takeovers in Western Australia is likely to rise after a change in ASX policy has simplified the process for emerging companies to access capital via existing entities.

Cough diagnosis app seeks capital

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A Perth based digital healthcare startup, ResApp Diagnostics has signed a heads of agreement to be fully acquired by Adam Sierakowski's Narhex Life Sciences.

Investors turn to innovation

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

FEATURE: Biotech and IT companies are enjoying renewed investor interest, but these innovative businesses are facing a changing capital raising market featuring less government support and, in Perth, a drastic shift in the venture capital sector.

Foodbank golfing classic coming

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

THERE is still room for businesses to get a piece of the action in the Foodbank Charity Golf Classic to be held at Lake Karrinyup Country Club on March 26.